Cargando…

mRNA Vaccines against Flaviviruses

Numerous vaccines have now been developed using the mRNA platform. In this approach, mRNA coding for a viral antigen is in vitro synthesized and injected into the host leading to exogenous protein expression and robust immune responses. Vaccines can be rapidly developed utilizing the mRNA platform i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wollner, Clayton J., Richner, Justin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918459/
https://www.ncbi.nlm.nih.gov/pubmed/33673131
http://dx.doi.org/10.3390/vaccines9020148
_version_ 1783657927198900224
author Wollner, Clayton J.
Richner, Justin M.
author_facet Wollner, Clayton J.
Richner, Justin M.
author_sort Wollner, Clayton J.
collection PubMed
description Numerous vaccines have now been developed using the mRNA platform. In this approach, mRNA coding for a viral antigen is in vitro synthesized and injected into the host leading to exogenous protein expression and robust immune responses. Vaccines can be rapidly developed utilizing the mRNA platform in the face of emerging pandemics. Additionally, the mRNA coding region can be easily manipulated to test novel hypotheses in order to combat viral infections which have remained refractory to traditional vaccine approaches. Flaviviruses are a diverse family of viruses that cause widespread disease and have pandemic potential. In this review, we discuss the mRNA vaccines which have been developed against diverse flaviviruses.
format Online
Article
Text
id pubmed-7918459
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79184592021-03-02 mRNA Vaccines against Flaviviruses Wollner, Clayton J. Richner, Justin M. Vaccines (Basel) Review Numerous vaccines have now been developed using the mRNA platform. In this approach, mRNA coding for a viral antigen is in vitro synthesized and injected into the host leading to exogenous protein expression and robust immune responses. Vaccines can be rapidly developed utilizing the mRNA platform in the face of emerging pandemics. Additionally, the mRNA coding region can be easily manipulated to test novel hypotheses in order to combat viral infections which have remained refractory to traditional vaccine approaches. Flaviviruses are a diverse family of viruses that cause widespread disease and have pandemic potential. In this review, we discuss the mRNA vaccines which have been developed against diverse flaviviruses. MDPI 2021-02-12 /pmc/articles/PMC7918459/ /pubmed/33673131 http://dx.doi.org/10.3390/vaccines9020148 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Wollner, Clayton J.
Richner, Justin M.
mRNA Vaccines against Flaviviruses
title mRNA Vaccines against Flaviviruses
title_full mRNA Vaccines against Flaviviruses
title_fullStr mRNA Vaccines against Flaviviruses
title_full_unstemmed mRNA Vaccines against Flaviviruses
title_short mRNA Vaccines against Flaviviruses
title_sort mrna vaccines against flaviviruses
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918459/
https://www.ncbi.nlm.nih.gov/pubmed/33673131
http://dx.doi.org/10.3390/vaccines9020148
work_keys_str_mv AT wollnerclaytonj mrnavaccinesagainstflaviviruses
AT richnerjustinm mrnavaccinesagainstflaviviruses